F&GFinance

The newsletter

Every autopsy, summarized in your inbox — plus the full reports for members once the paid tier opens. Free subscribers vote on which strategy gets tested next.

One honest strategy verdict, every week. No hype, no signals — just what survives real costs.

Join the newsletter →